{"schema_version":"secwatch.filing_event.v1","accession":"0000920148-24-000063","form_type":"8-K12B","ticker":"LH","cik":"0000920148","company_name":"LABCORP HOLDINGS INC.","filed_at":"2024-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.449864+00:00","generated_at":"2026-06-01T18:13:34.818012+00:00","sec_items":["1.01","2.03","3.01","3.03","5.01","5.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Labcorp completes holding company reorganization; Labcorp Holdings becomes new public parent","bullets":["Labcorp Holdings Inc. becomes successor issuer; shares convert 1:1 from Labcorp common stock.","LH ticker continues on NYSE uninterrupted; new CUSIP 504922105.","Directors, executive officers, and business operations unchanged; no change in control.","Labcorp Holdings guarantees Labcorp's senior notes and credit agreement via supplemental indenture and guarantor joinder.","Labcorp's authorized shares reduced to 1,000 common and 250 preferred; Labcorp Holdings authorized shares at 265M common and 30M preferred."],"urls":{"canonical":"https://secwatch.observer/filing/0000920148-24-000063","json":"https://secwatch.observer/filing/0000920148-24-000063.json","markdown":"https://secwatch.observer/filing/0000920148-24-000063.md","text":"https://secwatch.observer/filing/0000920148-24-000063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/lh-20240517.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T18:13:34.818012+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"98281de8aacc701c4f9d59a47242f4b2467dffa4","claim":"LABCORP HOLDINGS INC. underwent a change of control involving Laboratory Corporation of America Holdings (closed 2024-05-17).","evidence_excerpt":"On May 17, 2024, Labcorp implemented the Reorganization pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated as of May 17, 2024, among Labcorp, Labcorp Holdings Inc., a Delaware corporation (“Labcorp Holdings”) and Radiance Merger Sub Inc., a Delaware corporation and direct, wholly owned subsidiary of Labcorp Holdings (“Merger Sub”).","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","confidence":0.7,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"Laboratory Corporation of America Holdings"},{"label":"Closing","value":"2024-05-17"}]},{"claim_id":"0bbff5ecfd76888dbeba5609bab1561d760336bc","claim":"LABCORP HOLDINGS INC. entered into Seventeenth Supplemental Indenture with U.S. Bank Trust Company, National Association (effective 2024-05-17).","evidence_excerpt":"on May 17, 2024, Labcorp, Labcorp Holdings and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a seventeenth supplemental indenture (the “Seventeenth Supplemental Indenture\") to the indenture, dated as of November 19, 2010 between Labcorp and the Trustee","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"U.S. Bank Trust Company, National Association"},{"label":"Effective","value":"2024-05-17"}]},{"claim_id":"e2b2a2f22abe73069fa257bd429a8608ce99f561","claim":"LABCORP HOLDINGS INC. entered into Guarantor Joinder Agreement with Bank of America, N.A. (effective 2024-05-17).","evidence_excerpt":"On May 17, 2024, Labcorp Holdings entered into the Guarantor Joinder Agreement (the “Guarantor Joinder Agreement\"), pursuant to which, among other things, Labcorp Holdings provided a full and unconditional guarantee of Labcorp’s obligations under the Third Amended and Restated Credit Agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Bank of America, N.A."},{"label":"Effective","value":"2024-05-17"}]},{"claim_id":"ed216feaad5bf6df4f7929d1d48553cd8671f0b6","claim":"LABCORP HOLDINGS INC. entered into Merger Agreement with Merger Sub (effective 2024-05-17).","evidence_excerpt":"On May 17, 2024, Labcorp completed the Reorganization by implementing the Merger pursuant to the terms of the Merger Agreement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Merger Sub"},{"label":"Effective","value":"2024-05-17"}]}],"comparable_filings":[{"accession":"0000072162-26-000034","ticker":"NL","company_name":"NL INDUSTRIES INC","filed_at":"2026-05-26T20:16:09+00:00","headline":"NL Industries reincorporates in Delaware as NLI Holdings, effective May 26, 2026","event_type":"other_material","sec_items":["1.01","2.01","2.03","3.03","5.02","5.03","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.03, 3.03, 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000072162-26-000034","json":"https://secwatch.observer/filing/0000072162-26-000034.json","markdown":"https://secwatch.observer/filing/0000072162-26-000034.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/72162/000007216226000034/0000072162-26-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72162/000007216226000034/nl-20260519x8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"On May 17, 2024, Labcorp implemented the Reorganization pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated as of May 17, 2024, among Labcorp, Labcorp Holdings Inc., a Delaware corporation (“Labcorp Holdings”) and Radiance Merger Sub Inc., a Delaware corporation and direct, wholly owned subsidiary of Labcorp Holdings (“Merger Sub”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","comparable_excerpt":"Pursuant to the Plan of Merger, as of the Effective Time the Predecessor Corporation was merged with and into the Company, with the Company continuing as the surviving corporation.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/72162/000007216226000034/0000072162-26-000034-index.htm"}},{"accession":"0000790816-26-000019","ticker":null,"company_name":"BRANDYWINE OPERATING PARTNERSHIP, L.P.","filed_at":"2026-06-01T20:30:42+00:00","headline":"Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP","event_type":"other_material","sec_items":["1.01","2.03","5.02","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 2.03, 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000790816-26-000019","json":"https://secwatch.observer/filing/0000790816-26-000019.json","markdown":"https://secwatch.observer/filing/0000790816-26-000019.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1060386/000079081626000019/0000790816-26-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/790816/000079081626000019/bdn-20260528.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"on May 17, 2024, Labcorp, Labcorp Holdings and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a seventeenth supplemental indenture (the “Seventeenth Supplemental Indenture\") to the indenture, dated as of November 19, 2010 between Labcorp and the Trustee","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","comparable_excerpt":"tnership, L.P., a Delaware limited partnership (the “Operating Partnership” and, together with the Company, the “Borrowers”) extended the maturity date of the Borrowers’ revolving credit facility (the “Revolving Credit Facility”) provided under the Borrowers’ Second Amended and Restated Credit Agreement, dated as of June 30, 2022 (the “Credit Agreement”), by and among the Borrowers, Bank of America, N.A., as administrative agent and lender, and the other agents and lenders party thereto, for a period of six months from June 30, 2026 to December 30, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1060386/000079081626000019/0000790816-26-000019-index.htm"}},{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"on May 17, 2024, Labcorp, Labcorp Holdings and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a seventeenth supplemental indenture (the “Seventeenth Supplemental Indenture\") to the indenture, dated as of November 19, 2010 between Labcorp and the Trustee","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","comparable_excerpt":"On May 27, 2026, CPS Technologies Corp. (the “Company”) entered into securities purchase agreements (the “Purchase Agreements”) with certain institutional investors (the “Investors”) for the sale by the Company of 1,200,000 shares (the “Shares”) of its Common Stock, par value $0.01 per share (“Common Stock”), in a registered direct offering (the “Offering”), at a purchase price of $8.00 per share.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm"}},{"accession":"0001193125-26-253506","ticker":"JAGX","company_name":"Jaguar Health, Inc.","filed_at":"2026-06-02T20:10:13+00:00","headline":"Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8","event_type":"other_material","sec_items":["1.01","3.02","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253506","json":"https://secwatch.observer/filing/0001193125-26-253506.json","markdown":"https://secwatch.observer/filing/0001193125-26-253506.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/0001193125-26-253506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/d95782d8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"on May 17, 2024, Labcorp, Labcorp Holdings and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a seventeenth supplemental indenture (the “Seventeenth Supplemental Indenture\") to the indenture, dated as of November 19, 2010 between Labcorp and the Trustee","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","comparable_excerpt":"On May 26, 2026, the Company entered into a privately negotiated exchange agreement with Streeterville (the “First Exchange Agreement”), pursuant to which the Company issued 31,958 shares (the “First Exchange Shares”) of the Company’s common stock, par value $0.0001 (the “Common Stock”) to Streeterville in exchange for an aggregate of 3.72 outstanding shares of Series Q Preferred Stock held by Streeterville (the “First Exchanged Preferred Shares”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/0001193125-26-253506-index.htm"}},{"accession":"0001140361-26-023619","ticker":"GNK","company_name":"GENCO SHIPPING & TRADING LTD","filed_at":"2026-06-02T10:01:31+00:00","headline":"Genco Shipping amends shareholder rights plan, eliminates 'Acting in Concert' definition","event_type":"other_material","sec_items":["1.01","3.03","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-023619","json":"https://secwatch.observer/filing/0001140361-26-023619.json","markdown":"https://secwatch.observer/filing/0001140361-26-023619.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326200/000114036126023619/0001140361-26-023619-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326200/000114036126023619/ef20075333_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"on May 17, 2024, Labcorp, Labcorp Holdings and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a seventeenth supplemental indenture (the “Seventeenth Supplemental Indenture\") to the indenture, dated as of November 19, 2010 between Labcorp and the Trustee","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","comparable_excerpt":"On June 2, 2026, Genco Shipping & Trading Limited (the “ Company ”) entered into the Third Amendment to Shareholders Rights Agreement (the “ Third Amendment ”) to amend the Shareholder Rights Agreement, dated as of October 1, 2025 between the Company and Computershare Inc., as amended to date (the “ Rights Agreement ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1326200/000114036126023619/0001140361-26-023619-index.htm"}},{"accession":"0001193125-26-251789","ticker":"GIPR","company_name":"GENERATION INCOME PROPERTIES, INC.","filed_at":"2026-06-01T21:27:59+00:00","headline":"Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit","event_type":"other_material","sec_items":["1.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251789","json":"https://secwatch.observer/filing/0001193125-26-251789.json","markdown":"https://secwatch.observer/filing/0001193125-26-251789.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651721/000119312526251789/0001193125-26-251789-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651721/000119312526251789/gipr-20260528.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"on May 17, 2024, Labcorp, Labcorp Holdings and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a seventeenth supplemental indenture (the “Seventeenth Supplemental Indenture\") to the indenture, dated as of November 19, 2010 between Labcorp and the Trustee","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","comparable_excerpt":"In connection with the Offering, on May 28, 2026, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC, as placement agent","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1651721/000119312526251789/0001193125-26-251789-index.htm"}},{"accession":"0001493152-26-026890","ticker":"XWIN","company_name":"XMax Inc.","filed_at":"2026-06-02T20:30:36+00:00","headline":"XMax raises $3.6M via private placement of 486,500 shares at $7.347/share","event_type":"other_material","sec_items":["1.01","3.02","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026890","json":"https://secwatch.observer/filing/0001493152-26-026890.json","markdown":"https://secwatch.observer/filing/0001493152-26-026890.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1473334/000149315226026890/0001493152-26-026890-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1473334/000149315226026890/form8-k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"on May 17, 2024, Labcorp, Labcorp Holdings and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a seventeenth supplemental indenture (the “Seventeenth Supplemental Indenture\") to the indenture, dated as of November 19, 2010 between Labcorp and the Trustee","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","comparable_excerpt":"On May 28, 2026, XMax Inc. (the “ Company ”) entered into Securities Purchase Agreements (the “ Agreements ”) with certain non-U.S. investors identified on the signature pages thereto (the “ Purchasers ”), pursuant to which the Company agreed to sell to the Purchasers in a private placement for a total of 486,500 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), at a purchase price of $7.347 per share for an aggregate offering price of $3,574,315.50 (the “ Private Placement ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1473334/000149315226026890/0001493152-26-026890-index.htm"}},{"accession":"0001193125-26-253577","ticker":"RPM","company_name":"RPM INTERNATIONAL INC/DE/","filed_at":"2026-06-02T20:25:45+00:00","headline":"RPM amends $300M A/R securitization facility; VP-Operations Kinser reassigned to subsidiary role","event_type":"other_material","sec_items":["1.01","5.02"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 5.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253577","json":"https://secwatch.observer/filing/0001193125-26-253577.json","markdown":"https://secwatch.observer/filing/0001193125-26-253577.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/110621/000119312526253577/0001193125-26-253577-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/110621/000119312526253577/d141677d8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"on May 17, 2024, Labcorp, Labcorp Holdings and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a seventeenth supplemental indenture (the “Seventeenth Supplemental Indenture\") to the indenture, dated as of November 19, 2010 between Labcorp and the Trustee","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000063/0000920148-24-000063-index.htm","comparable_excerpt":"On May 27, 2026, RPM International Inc. (the “Company”) amended its existing $300.0 million accounts receivable securitization facility (the “A/R Facility”) by entering into (i) Amendment No. 11 to Amended and Restated Receivables Purchase Agreement, dated as of May 27, 2026 (the “RPA Amendment”), among the Company, RPM Funding Corporation, a special purpose entity (the “SPE”) whose voting interests are wholly owned by the Company, certain purchasers from time to time party thereto, PNC Bank, National Association, as administrative agent, and PNC Capital Markets LLC, as structuring agent, and (ii) Amendment No. 14 to Second Amended and Restated Receivables Sale Agreement, dated as of May 27, 2026 (the “RSA Amendment”, and together with the RPA Amendment, the “Amendments”), among certain subsidiaries of the Company (the “Originators”) and the SPE.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/110621/000119312526253577/0001193125-26-253577-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}